Plasma lipids are associated with white matter microstructural changes and axonal degeneration.


Journal

Brain imaging and behavior
ISSN: 1931-7565
Titre abrégé: Brain Imaging Behav
Pays: United States
ID NLM: 101300405

Informations de publication

Date de publication:
Apr 2021
Historique:
pubmed: 5 8 2020
medline: 28 4 2021
entrez: 5 8 2020
Statut: ppublish

Résumé

Dislipidemia is a risk factor for cognitive impairment. We studied the association between interindividual variability of plasma lipids and white matter (WM) microstructure, using diffusion tensor imaging (DTI) in 273 healthy adults. Special focus was placed on 7 regions of interest (ROI) which are structural components of cognitive neurocircuitry. We also investigated the effect of plasma lipids on cerebrospinal fluid (CSF) neurofilament light chain (NfL), an axonal degeneration marker. Low density lipoprotein (LDL) and triglyceride (TG) levels showed a negative association with axial diffusivity (AxD) in multiple regions. High density lipoproteins (HDL) showed a positive correlation. The association was independent of Apolipoprotein E (APOE) genotype, blood pressure or use of statins. LDL moderated the relation between NfL and AxD in the body of the corpus callosum (p = 0.041), right cingulum gyrus (p = 0.041), right fornix/stria terminalis (p = 0.025) and right superior longitudinal fasciculus (p = 0.020) and TG in the right inferior longitudinal fasciculus (p = 0.004) and left fornix/stria terminalis (p = 0.001). We conclude that plasma lipids are associated to WM microstructural changes and axonal degeneration and might represent a risk factor in the transition from healthy aging to disease.

Identifiants

pubmed: 32748320
doi: 10.1007/s11682-020-00311-9
pii: 10.1007/s11682-020-00311-9
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1043-1057

Références

Abraham, H. M. A., Wolfson, L., Moscufo, N., Guttmann, C. R. G., Kaplan, R. F., & White, W. B. (2016). Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older persons. Journal of Cerebral Blood Flow & Metabolism, 36(1), 132–142. https://doi.org/10.1038/jcbfm.2015.121 .
doi: 10.1038/jcbfm.2015.121
Adalbert, R., & Coleman, M. P. (2013). Review: Axon pathology in age-related neurodegenerative disorders. Neuropathology and Applied Neurobiology, 39(2), 90–108. https://doi.org/10.1111/j.1365-2990.2012.01308.x .
doi: 10.1111/j.1365-2990.2012.01308.x pubmed: 23046254
Aikawa, T., Holm, M. L., & Kanekiyo, T. (2018). ABCA7 and pathogenic pathways of Alzheimer’s disease. Brain Sciences, 8(2), 27. https://doi.org/10.3390/brainsci8020027 .
doi: 10.3390/brainsci8020027 pmcid: 5836046
Alexander, A. L., Lee, J. E., Lazar, M., & Field, A. S. (2007). Diffusion tensor imaging of the brain. Neurotherapeutics, 4(3), 316–329. https://doi.org/10.1016/j.nurt.2007.05.011 .
doi: 10.1016/j.nurt.2007.05.011 pubmed: 17599699 pmcid: 2041910
Aljondi, R., Szoeke, C., Steward, C., Gorelik, A., & Desmond, P. (2020). The effect of midlife cardiovascular risk factors on white matter hyperintensity volume and cognition two decades later in normal ageing women. Brain Imaging and Behavior, 14(1), 51–61. https://doi.org/10.1007/s11682-018-9970-5 .
doi: 10.1007/s11682-018-9970-5 pubmed: 30259291
Andersson, J. L. R., Jenkinson, M., & Smith, S. (2007). Non-linear registration aka spatial normalisation FMRIB technical report TR07JA2. FMRIB Analysis Group of the University of Oxford.
Andersson, J. L. R., & Sotiropoulos, S. N. (2016). An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. NeuroImage, 125, 1063–1078. https://doi.org/10.1016/j.neuroimage.2015.10.019 .
doi: 10.1016/j.neuroimage.2015.10.019 pubmed: 26481672 pmcid: 4692656
Bartzokis, G., Lu, P. H., Heydari, P., Couvrette, A., Lee, G. J., Kalashyan, G., Freeman, F., Grinstead, J. W., Villablanca, P., Finn, J. P., Mintz, J., Alger, J. R., & Altshuler, L. L. (2012). Multimodal magnetic resonance imaging assessment of white matter aging trajectories over the lifespan of healthy individuals. Biological Psychiatry, 72(12), 1026–1034. https://doi.org/10.1016/j.biopsych.2012.07.010 .
doi: 10.1016/j.biopsych.2012.07.010 pubmed: 23017471
Benitez, A., Fieremans, E., Jensen, J. H., Falangola, M. F., Tabesh, A., Ferris, S. H., & Helpern, J. A. (2014). White matter tract integrity metrics reflect the vulnerability of late-myelinating tracts in Alzheimer’s disease. NeuroImage: Clinical, 4, 64–71. https://doi.org/10.1016/j.nicl.2013.11.001 .
doi: 10.1016/j.nicl.2013.11.001
Birdsill, A. C., Oleson, S., Kaur, S., Pasha, E., Ireton, A., Tanaka, H., & Haley, A. (2017). Abdominal obesity and white matter microstructure in midlife. Human Brain Mapping, 38, 3337–3344. https://doi.org/10.1002/hbm.23576 .
doi: 10.1002/hbm.23576 pubmed: 28390146 pmcid: 5632566
Blazquez, L., De, J. D., Ruiz-Martinez, J., Emparanza, J. I., Saenz, A., Otaegui, D., et al. (2007). Genes related to iron metabolism and susceptibility to Alzheimer’s disease in Basque population. Neurobiology of Aging, 28(12), 1941–1943. https://doi.org/10.1016/j.neurobiolaging.2006.08.009 .
doi: 10.1016/j.neurobiolaging.2006.08.009 pubmed: 17011669
Blesa, R., Pujol, M., Aguilar, M., Santacruz, P., Bertran-Serra, I., Hernández, G., et al. (2001). Clinical validity of the “mini-mental state” for Spanish speaking communities. Neuropsychologia, 39(11), 1150–1157. https://doi.org/10.1016/s0028-3932(01)00055-0 .
Borghesani, P. R., Madhyastha, T. M., Aylward, E. H., Reiter, M. A., Swarny, B. R., Schaie, K. W., & Willis, S. L. (2013). The association between higher order abilities, processing speed, and age are variably mediated by white matter integrity during typical aging. Neuropsychologia, 51(8), 1435–1444. https://doi.org/10.1016/j.neuropsychologia.2013.03.005 .
doi: 10.1016/j.neuropsychologia.2013.03.005 pubmed: 23507612
Cahua-Pablo, G., Cruz, M., Del Moral-Hernández, O., Leyva-Vázquez, M. A., Antú Nez-Ortiz, D. L., Cahua-Pablo, J. A., et al. (2016). Elevated levels of LDL-C are associated with ApoE4 but not with the rs688 polymorphism in the LDLR gene. Clinical and Applied Thrombosis/Hemostasis, 22(5), 465–470. https://doi.org/10.1177/1076029614568714 .
doi: 10.1177/1076029614568714
Cavedo, E., Lista, S., Rojkova, K., Chiesa, P. A., Houot, M., Brueggen, K., Blautzik, J., Bokde, A. L. W., Dubois, B., Barkhof, F., Pouwels, P. J. W., Teipel, S., Hampel, H., & Alzheimer Precision Medicine Initiative (APMI). (2017). Disrupted white matter structural networks in healthy older adult APOE ε4 carriers - An international multicenter DTI study. Neuroscience, 357, 119–133. https://doi.org/10.1016/j.neuroscience.2017.05.048 .
doi: 10.1016/j.neuroscience.2017.05.048 pubmed: 28596117
Cohen, J., Cazettes, F., & Convit, A. (2011). Abnormal cholesterol is associated with prefrontal white matter abnormalities among obese adults, a diffusion tensor imaging study. The Neuroradiology Journal, 1(21), 989–997. https://doi.org/10.1016/j.surg.2006.10.010.Use .
doi: 10.1016/j.surg.2006.10.010.Use pubmed: 22163070 pmcid: 3234114
Davis, S. W., Dennis, N. A., Buchler, N. G., White, L. E., Madden, D. J., & Cabeza. (2009). Assessing the effects of age on long white matter tracts using diffusion tensor tractography. NeuroImage, 46(2), 530–541. https://doi.org/10.1016/j.neuroimage.2009.01.068 .
doi: 10.1016/j.neuroimage.2009.01.068 pubmed: 19385018 pmcid: 2775533
Dietschy, J. M. (2009). Central nervous system: Cholesterol turnover, brain development and neurodegeneration. Biological Chemistry, 390(4), 287–293. https://doi.org/10.1515/BC.2009.035 .
doi: 10.1515/BC.2009.035 pubmed: 19166320 pmcid: 3066069
Ecay-Torres, M., Estanga, A., Tainta, M., Izagirre, A., Garcia-Sebastian, M., Villanua, J., Clerigue, M., Iriondo, A., Urreta, I., Arrospide, A., Díaz-Mardomingo, C., Kivipelto, M., & Martinez-Lage, P. (2018). Increased CAIDE dementia risk, cognition, CSF biomarkers, and vascular burden in healthy adults. Neurology, 91(3), e217–e2226. https://doi.org/10.1212/WNL.0000000000005824 .
Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I., & Zimmerman, R. A. (1987). MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. American Journal of Roentgenology, 149(2), 351–356. https://doi.org/10.2214/ajr.149.2.351 .
doi: 10.2214/ajr.149.2.351 pubmed: 3496763
Griffiths, H., Irundika, D., Lip, G., Spickett, C., & Polidori, C. (2014). Oxidised LDL lipids, statins and a blood-brain barrier. Free Radical Biology and Medicine, 75, S15–S16. https://doi.org/10.1016/j.freeradbiomed.2014.10.591 .
doi: 10.1016/j.freeradbiomed.2014.10.591 pubmed: 26461292
Hainsworth, A. H., Minett, T., Andoh, J., Forster, G., Bhide, I., Barrick, T. R., Elderfield, K., Jeevahan, J., Markus, H. S., & Bridges, L. R. (2017). Neuropathology of white matter lesions, blood-brain barrier dysfunction, and dementia. Stroke, 48(10), 2799–2804. https://doi.org/10.1161/STROKEAHA.117.018101 .
doi: 10.1161/STROKEAHA.117.018101 pubmed: 28855392 pmcid: 5986073
Iniciativa Panamericana Sobre La Hipertensión. (2003). Working meeting on blood pressure measurement: Suggestions for measuring blood pressure to use in populations surveys. Revista Panamericana de Salud Publica, 14(5), 300–302, 303–305. https://doi.org/10.1590/s1020-49892003001000003 .
doi: 10.1590/s1020-49892003001000003
Iuliano, L., Crick, P. J., Zerbinati, C., Tritapepe, L., Abdel-Khalik, J., Poirot, M., Wang, Y., & Griffiths, W. J. (2015). Cholesterol metabolites exported from human brain. Steroids, 99, 189–193. https://doi.org/10.1016/j.steroids.2015.01.026 .
doi: 10.1016/j.steroids.2015.01.026 pubmed: 25668615 pmcid: 4503873
Jacob, A., & Alexander, J. J. (2014). Complement and blood–brain barrier integrity. Molecular Immunology, 61(2), 149–152. https://doi.org/10.1016/j.molimm.2014.06.039 .
doi: 10.1016/j.molimm.2014.06.039 pubmed: 25041699
Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W., & Smith, S. M. (2012). FSL. NeuroImage, 62(2), 782–790. https://doi.org/10.1016/j.neuroimage.2011.09.015 .
doi: 10.1016/j.neuroimage.2011.09.015 pubmed: 21979382 pmcid: 21979382
Kennedy, K. M., & Raz, N. (2009). Pattern of normal age-related regional differences in white matter microstructure is modified by vascular risk. Brain Research, 1297, 41–56. https://doi.org/10.1016/j.brainres.2009.08.058 .
doi: 10.1016/j.brainres.2009.08.058 pubmed: 19712671 pmcid: 2758325
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., Petzold, A., Blennow, K., Zetterberg, H., & Kuhle, J. (2018). Neurofilaments as biomarkers in neurological disorders. Nature Reviews Neurology, 14(10), 577–589. https://doi.org/10.1038/s41582-018-0058-z .
doi: 10.1038/s41582-018-0058-z pubmed: 30171200
Kraft, P., Schuhmann, M. K., Garz, C., Jandke, S., Urlaub, D., Mencl, S., Zernecke, A., Heinze, H. J., Carare, R. O., Kleinschnitz, C., & Schreiber, S. (2017). Hypercholesterolemia induced cerebral small vessel disease. PLoS One, 12(8), e0182822. https://doi.org/10.1371/journal.pone.0182822 .
doi: 10.1371/journal.pone.0182822 pubmed: 28796818 pmcid: 5552130
Kullmann, S., Callaghan, M. F., Heni, M., Weiskopf, N., Scheffler, K., Häring, H.-U., Fritsche, A., Veit, R., & Preissl, H. (2016). Specific white matter tissue microstructure changes associated with obesity. NeuroImage, 125, 36–44. https://doi.org/10.1016/j.neuroimage.2015.10.006 .
doi: 10.1016/j.neuroimage.2015.10.006 pubmed: 26458514 pmcid: 4692452
Leritz, E. C., Salat, D. H., Milberg, W. P., Williams, V. J., Chapman, C. E., Grande, L. J., Rudolph, J. L., Schnyer, D. M., Barber, C. E., Lipsitz, L. A., & McGlinchey, R. E. (2010). Variation in blood pressure is associated with white matter microstructure but not cognition in African Americans. Neuropsychology, 24(2), 199–208. https://doi.org/10.1037/a0018108 .
doi: 10.1037/a0018108 pubmed: 20230114 pmcid: 2849283
Li, H., Zhou, J., Yue, Z., Feng, L., Luo, Z., Chen, S., Yang, X., & Xiao, B. (2017). A complex association between ABCA7 genotypes and blood lipid levels in southern Chinese Han patients of sporadic Alzheimer’s disease. Journal of the Neurological Sciences, 382, 13–17. https://doi.org/10.1016/j.jns.2017.09.016 .
doi: 10.1016/j.jns.2017.09.016 pubmed: 29111006
Madden, D. J., Bennett, I. J., & Song, A. W. (2009). Cerebral White matter integrity and cognitive aging: Contributions from diffusion tensor imaging. Neuropsychology Review, 19(4), 415–435. https://doi.org/10.1007/s11065-009-9113-2 .
doi: 10.1007/s11065-009-9113-2 pubmed: 19705281 pmcid: 2787975
Mayo, C. D., Garcia-Barrera, M. A., Mazerolle, E. L., Ritchie, L. J., Fisk, J. D., & Gawryluk, J. R. (2019). Relationship between DTI metrics and cognitive function in Alzheimer’s disease. Frontiers in Aging Neuroscience, 10, 436. https://doi.org/10.3389/fnagi.2018.00436 .
doi: 10.3389/fnagi.2018.00436 pubmed: 30687081 pmcid: 6333848
Melah, K. E., Yuan-Fu Lu, S., Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., et al. (2016). CSF markers of Alzheimer’s pathology and microglial activation are associated with altered white matter microstructure in asymptomatic adults at risk for Alzheimer’s disease. Journal of Alzheimers Disease, 50(3), 873–886. https://doi.org/10.3233/JAD-150897 .
doi: 10.3233/JAD-150897
Moore, E. E., Hohman, T. J., Badami, F. S., Pechman, K. R., Osborn, K. E., Acosta, L. M. Y., Bell, S. P., Babicz, M. A., Gifford, K. A., Anderson, A. W., Goldstein, L. E., Blennow, K., Zetterberg, H., & Jefferson, A. L. (2018). Neurofilament relates to white matter microstructure in older adults. Neurobiology of Aging, 70, 233–241. https://doi.org/10.1016/j.neurobiolaging.2018.06.023 .
doi: 10.1016/j.neurobiolaging.2018.06.023 pubmed: 30036759 pmcid: 6119102
Morris, J. C. (1993). The clinical dementia rating (CDR): Current version and scoring rules. Neurology, 43(11), 2412–2414. https://doi.org/10.1212/wnl.43.11.2412-a .
doi: 10.1212/wnl.43.11.2412-a pubmed: 8232972
Operto, G., Cacciaglia, R., Grau-Rivera, O., Falcon, C., Brugulat-Serrat, A., Ródenas, P., et al. (2018). White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes. Alzheimer’s Research & Therapy, 10(1), 48. https://doi.org/10.1186/s13195-018-0375-x .
doi: 10.1186/s13195-018-0375-x
Racine, A. M., Merluzzi, A. P., Adluru, N., Norton, D., Koscik, R. L., Clark, L. R., et al. (2019). Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer’s disease in late-middle-aged adults. Brain Imaging and Behavior, 13(1), 41–52. https://doi.org/10.1007/s11682-017-9732-9 .
doi: 10.1007/s11682-017-9732-9 pubmed: 28600739 pmcid: 5723250
Ramanan, V. K., Przybelski, S. A., Graff-Radford, J., Castillo, A. M., Lowe, V. J., Mielke, M. M., Roberts, R. O., Reid, R. I., Knopman, D. S., Jack, C. R., Petersen, R. C., & Vemuri, P. (2018). Statins and brain health: Alzheimer’s and cerebrovascular disease biomarkers in older adults. Journal of Alzheimers Disease, 65(4), 1345–1352. https://doi.org/10.3233/JAD-180446 .
doi: 10.3233/JAD-180446
Ramirez, L. M., Goukasian, N., Porat, S., Hwang, K. S., Eastman, J. A., Hurtz, S., Wang, B., Vang, N., Sears, R., Klein, E., Coppola, G., & Apostolova, L. G. (2016). Common variants in ABCA7 and MS4A6A are associated with cortical and hippocampal atrophy. Neurobiology of Aging, 39, 82–89. https://doi.org/10.1016/j.neurobiolaging.2015.10.037 .
doi: 10.1016/j.neurobiolaging.2015.10.037 pubmed: 26923404
Roshchupkin, G. V., Adams, H. H., van der Lee, S. J., Vernooij, M. W., van Duijn, C. M., Uitterlinden, A. G., van der Lugt, A., Hofman, A., Niessen, W. J., & Ikram, M. A. (2016). Fine-mapping the effects of Alzheimer’s disease risk loci on brain morphology. Neurobiology of Aging, 48, 204–211. https://doi.org/10.1016/j.neurobiolaging.2016.08.024 .
doi: 10.1016/j.neurobiolaging.2016.08.024 pubmed: 27718423
Rueckert, D., Sonoda, L. I., Hayes, C., Hill, D. L. G., Leach, M. O., & Hawkes, D. J. (1999). Nonrigid registration using free-form deformations: Application to breast MR images. IEEE Transactions on Medical Imaging, 18(8), 712–721. https://doi.org/10.1109/42.796284 .
doi: 10.1109/42.796284 pubmed: 10534053
Ryu, C.-W., Coutu, J.-P., Greka, A., Rosas, H. D., Jahng, G.-H., Rosen, B. R., & Salat, D. H. (2017). Differential associations between systemic markers of disease and white matter tissue health in middle-aged and older adults. Journal of Cerebral Blood Flow and Metabolism, 37(11), 3568–3579. https://doi.org/10.1177/0271678X16653613 .
doi: 10.1177/0271678X16653613 pubmed: 27298238
Salami, A., Eriksson, J., Nilsson, L.-G., & Nyberg, L. (2012). Age-related white matter microstructural differences partly mediate age-related decline in processing speed but not cognition. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1822(3), 408–415. https://doi.org/10.1016/j.bbadis.2011.09.001 .
doi: 10.1016/j.bbadis.2011.09.001
Salat, D. H., Williams, V. J., Leritz, E. C., Schnyer, D. M., Rudolph, J. L., Lipsitz, L. A., McGlinchey, R. E., & Milberg, W. P. (2012). Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults. NeuroImage, 59(1), 181–192. https://doi.org/10.1016/j.neuroimage.2011.07.033 .
doi: 10.1016/j.neuroimage.2011.07.033 pubmed: 21820060
Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017). Axonal degeneration during aging and its functional role in neurodegenerative disorders. Frontiers in Neuroscience, 11, 451. https://doi.org/10.3389/fnins.2017.00451 .
doi: 10.3389/fnins.2017.00451 pubmed: 28928628 pmcid: 5591337
Smit, R. A. J., Trompet, S., Sabayan, B., le Cessie, S., van der Grond, J., van Buchem, M. A., de Craen, A. J. M., & Jukema, J. W. (2016). Higher visit-to-visit low-density lipoprotein cholesterol variability is associated with lower cognitive performance, lower cerebral blood flow, and greater White matter Hyperintensity load in older SubjectsClinical perspective. Circulation, 134(3), 212–221. https://doi.org/10.1161/CIRCULATIONAHA.115.020627 .
doi: 10.1161/CIRCULATIONAHA.115.020627 pubmed: 27436880
Smith, S. M. (2002). Fast robust automated brain extraction. Human Brain Mapping, 17(3), 143–155. https://doi.org/10.1002/hbm.10062 .
doi: 10.1002/hbm.10062 pubmed: 12391568 pmcid: 6871816
Smith, S. M., Jenkinson, M., Johansen-Berg, H., Rueckert, D., Nichols, T. E., Mackay, C. E., Watkins, K. E., Ciccarelli, O., Cader, M. Z., Matthews, P. M., & Behrens, T. E. J. (2006). Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. NeuroImage, 31(4), 1487–1505. https://doi.org/10.1016/j.neuroimage.2006.02.024 .
doi: 10.1016/j.neuroimage.2006.02.024 pubmed: 16624579
Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E. J., Johansen-Berg, H., Bannister, P. R., de Luca, M., Drobnjak, I., Flitney, D. E., Niazy, R. K., Saunders, J., Vickers, J., Zhang, Y., de Stefano, N., Brady, J. M., & Matthews, P. M. (2004). Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage, 23, S208–S219. https://doi.org/10.1016/j.neuroimage.2004.07.051 .
doi: 10.1016/j.neuroimage.2004.07.051 pubmed: 15501092
Smith, S. M., & Nichols, T. E. (2009). Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage, 44(1), 83–98. https://doi.org/10.1016/j.neuroimage.2008.03.061 .
doi: 10.1016/j.neuroimage.2008.03.061 pubmed: 18501637
Solomon, A., Leoni, V., Kivipelto, M., Besga, A., Oksengard, A. R., Julin, P., et al. (2009). Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer’s disease. Neuroscience Letters, 462(1), 89–93. https://doi.org/10.1016/j.neulet.2009.06.073 .
doi: 10.1016/j.neulet.2009.06.073 pubmed: 19560513
Song, S.-K., Sun, S.-W., Ramsbottom, M. J., Chang, C., Russell, J., & Cross, A. H. (2002). Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. NeuroImage, 17(3), 1429–1436. https://doi.org/10.1006/nimg.2002.1267 .
doi: 10.1006/nimg.2002.1267 pubmed: 12414282
Song, S.-K., Yoshino, J., Le, T. Q., Lin, S.-J., Sun, S.-W., Cross, A. H., & Armstrong, R. C. (2005). Demyelination increases radial diffusivity in corpus callosum of mouse brain. NeuroImage, 26(1), 132–140. https://doi.org/10.1016/j.neuroimage.2005.01.028 .
doi: 10.1016/j.neuroimage.2005.01.028 pubmed: 15862213
Stricker, N. H., Schweinsburg, B. C., Delano-Wood, L., Wierenga, C. E., Bangen, K. J., Haaland, K. Y., Frank, L. R., Salmon, D. P., & Bondi, M. W. (2009). Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer’s disease supports retrogenesis. NeuroImage, 1(451), 10–16. https://doi.org/10.1016/j.neuroimage.2008.11.027 .
doi: 10.1016/j.neuroimage.2008.11.027
Tall, A. R., & Yvan-Charvet, L. (2015). Cholesterol, inflammation and innate immunity. Nature Reviews. Immunology, 15(2), 104–116. https://doi.org/10.1038/nri3793 .
doi: 10.1038/nri3793 pubmed: 25614320 pmcid: 4669071
Tournier, J.-D., Mori, S., Leemans, A., & Morgan, R. H. (2011). Diffusion tensor imaging and beyond. Magnetic Resonance in Medicine, 65(6), 1532–1556. https://doi.org/10.1002/mrm.22924 .
doi: 10.1002/mrm.22924 pubmed: 21469191 pmcid: 3366862
van Leijsen, E. M. C., Bergkamp, M. I., van Uden, I. W. M., Ghafoorian, M., van der Hoslt, H. M., Norris, D. G., et al. (2018). Progression of White matter Hyperintensities preceded by heterogeneous decline of microstructural integrity. Stroke, 49(6), 1386–1393. https://doi.org/10.1161/STROKEAHA.118.020980 .
doi: 10.1161/STROKEAHA.118.020980
Vangberg, T. R., Eikenes, L., & Håberg, A. K. (2019). The effect of white matter hyperintensities on regional brain volumes and white matter microstructure, a population-based study in HUNT. NeuroImage, 203, 116158. https://doi.org/10.1016/j.neuroimage.2019.116158 .
doi: 10.1016/j.neuroimage.2019.116158 pubmed: 31493533
Wang, R., Fratiglioni, L., Laukka, E. J., Lovden, M., Kalpouzos, G., Keller, L., et al. (2015). Effects of vascular risk factors and APOE 4 on white matter integrity and cognitive decline. Neurology, 84(11), 1128–1135. https://doi.org/10.1212/WNL.0000000000001379 .
doi: 10.1212/WNL.0000000000001379 pubmed: 25672924 pmcid: 4371409
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., Black, S. E., Brayne, C., Breteler, M., Chabriat, H., Decarli, C., de Leeuw, F. E., Doubal, F., Duering, M., Fox, N. C., Greenberg, S., Hachinski, V., Kilimann, I., Mok, V., Oostenbrugge Rv, Pantoni, L., Speck, O., Stephan, B. C., Teipel, S., Viswanathan, A., Werring, D., Chen, C., Smith, C., van Buchem, M., Norrving, B., Gorelick, P. B., Dichgans, M., & STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). (2013). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet Neurology, 12(8), 822–838. https://doi.org/10.1016/S1474-4422(13)70124-8 .
doi: 10.1016/S1474-4422(13)70124-8 pubmed: 23867200 pmcid: 3714437
Warstadt, N. M., Dennis, E. L., Jahanshad, N., Kohannim, O., Nir, T. M., Mcmahon, K. L., et al. (2014). Serum cholesterol and variant in cholesterol-related gene CETP predict White matter microstructure and for the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Neurobiology of Aging, 35(11), 2504–2513. https://doi.org/10.1016/j.neurobiolaging.2014.05.024 .
doi: 10.1016/j.neurobiolaging.2014.05.024 pubmed: 24997672 pmcid: 4198330
Wheeler-Kingshott, C. A. M., & Cercignani, M. (2009). About axial and radial diffusivities. Magnetic Resonance in Medicine, 61, 1255–1260. https://doi.org/10.1002/mrm.21965 .
doi: 10.1002/mrm.21965 pubmed: 19253405
Williams, O. A., An, Y., Beason-Held, L., Huo, Y., Ferrucci, L., Landman, B. A., & Resnick, S. M. (2019). Vascular burden and APOE ε4 are associated with white matter microstructural decline in cognitively normal older adults. NeuroImage, 188, 572–583. https://doi.org/10.1016/j.neuroimage.2018.12.009 .
doi: 10.1016/j.neuroimage.2018.12.009 pubmed: 30557663
Williams, V. J., Leritz, E. C., Shepel, J., Mcglinchey, R. E., Milberg, W. P., Rudolph, J. L., et al. (2013). Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults. Human Brain Mapping, 34(8), 1826–1841. https://doi.org/10.1002/hbm.22030 .
doi: 10.1002/hbm.22030 pubmed: 22438182
Winklewski, P. J., Sabisz, A., Naumczyk, P., Jodzio, K., Szurowska, E., & Szarmach, A. (2018). Understanding the physiopathology behind axial and radial diffusivity changes-what do we know? Frontiers in Neurology, 9, 92. https://doi.org/10.3389/fneur.2018.00092 .
doi: 10.3389/fneur.2018.00092 pubmed: 29535676 pmcid: 5835085
Woolrich, M. W., Jbabdi, S., Patenaude, B., Chappell, M., Makni, S., Behrens, T., Beckmann, C., Jenkinson, M., & Smith, S. M. (2009). Bayesian analysis of neuroimaging data in FSL. NeuroImage, 45(1), S173–S186. https://doi.org/10.1016/j.neuroimage.2008.10.055 .
doi: 10.1016/j.neuroimage.2008.10.055 pubmed: 19059349
Zhang, R., Beyer, F., Lampe, L., Luck, T., Riedel-Heller, S. G., Loeffler, M., Schroeter, M. L., Stumvoll, M., Villringer, A., & Witte, A. V. (2018). White matter microstructural variability mediates the relation between obesity and cognition in healthy adults. NeuroImage, 172, 239–249. https://doi.org/10.1016/j.neuroimage.2018.01.028 .
doi: 10.1016/j.neuroimage.2018.01.028 pubmed: 29378320
Zhuang, L., Sachdev, P. S., Trollor, J. N., Reppermund, S., Kochan, N. A., Brodaty, H., & Wen, W. (2013). Microstructural White matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment. PLoS One, 8(3), e58887. https://doi.org/10.1371/journal.pone.0058887 .
doi: 10.1371/journal.pone.0058887 pubmed: 23516569 pmcid: 3597581

Auteurs

Ane Iriondo (A)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain.

Maite García-Sebastian (M)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain.

Arantzazu Arrospide (A)

Gipuzkoa Primary Care - Integrated Health Care Organizations Research Unit. Alto Deba Integrated Health Care Organisation, Arrasate, Spain.
Biodonostia Health Research Institute, Donostia-San Sebastian, Spain.

Maria Arriba (M)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain.

Sara Aurtenetxe (S)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain.

Myriam Barandiaran (M)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain.

Montserrat Clerigue (M)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain.

Mirian Ecay-Torres (M)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain.

Ainara Estanga (A)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain.

Alazne Gabilondo (A)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain.

Andrea Izagirre (A)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain.
Department of Nursing II, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain.

Jon Saldias (J)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain.

Mikel Tainta (M)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain.

Jorge Villanua (J)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain.

Javier Mar (J)

Gipuzkoa Primary Care - Integrated Health Care Organizations Research Unit. Alto Deba Integrated Health Care Organisation, Arrasate, Spain.
Biodonostia Health Research Institute, Donostia-San Sebastian, Spain.

Felix M Goñi (FM)

Departamento de Bioquímica, University of the Basque Country (UPV/EHU) and Instituto Biofisika (CSIC, UPV/EHU), Leioa, Spain.

Pablo Martínez-Lage (P)

Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Donostia-San Sebastian, Spain. pmlage@cita-alzheimer.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH